Dalmia Biz Education
Limited has
signed a Memorandum of Understanding with several medical universities in CIS
countries that are recognized by World Health Organization and offer 5 years
course in Doctor of Medicine (MD) in English language. Under the arrangement,
the company will facilitate Indian students to study medicine abroad and
prepare them to pass the Indian National Medical Commission exams namely
Foreign Medical Graduate Exam (FMGE)/National Exit Test (NExT). Dalmia Biz
Education will identify, shortlist and screen the students as per the
eligibility criteria and standards of the University. Finally, the most
competent student profiles will be forwarded for university program enrolments.
Post successful completion of the program, Dalmia Healthcare Limited - a Dalmia
group venture into healthcare domain will provide 100% assistance to these
professionals for their placements or setting up their healthcare centers in
India.
Sanjay Dalmia, the
Chairman of Dalmia group commented, “We
have an unprecedented opportunity to create a world-class medical education
system, well equipped with modern and technologically advanced infrastructure.
We are on a mission to contribute in developing a strong foundation in medical
education domain to support India in harnessing its demographic dividend to
become a “Vishwa
Guru” once
again.”
He further stated
that “Over 50% of the
students from CIS countries, who aren’t able to clear the FMGE or NEXT
examination, conducted by NMC every year, fail to fulfill their career goals.
Dalmia Group has proposed to setup an online facility, for the best in-class
training of these students, through especially designed courses mapped to the
Indian requirements to qualify the test.”
Dalmia Group’s move is in
line with government’s objective of transforming medical education and making
it affordable and accessible for every aspiring student. Recently, PM Narendra
Modi in his speech said that the nation is set to have a record number of
doctors in the next 10 years.
Dalmia Biz Education is
set to build a strong presence in the education space with the Foreign Medical
Students Program with CIS countries. The company is also entering into the
school business from April-June quarter with the sole aim of transforming
education and to make it affordable for all.
Dalmia Healthcare Limited
is set to build a robust presence across the healthcare ecosystem, including
Hospitals, Diagnostic Clinics, Pharmacies (Ayurvedic & Allopathic) and
Medical Tourism. The company provides plant-based formulations (Ayurvedic/herbal)
and allopathic drugs, that have undergone rigorous scientific validation and
clinical trials, conducted at its research centre, Dalmia Centre for Research
and Development (DCRD). The company has a presence in more than 30 countries
globally, including South-Eastern European countries, Latin America, CIS
countries etc.